References

  1. McNamara JO. Drugs effective in the therapy of the epilepsies, in: Hardman JG, Limberd LE, Gilman AG, eds: Goodman and Gilman's pharmacological basis of therapeutics, 10th ed. New York: McGraw Hill. 2001; 521-547. Google Scholar

  2. Arceci RJ, Croop JM, Horwitz SB, Housman DE. The gene encoding multidrug resistance is induced andexpressed at high levels during pregnancy in the secretory epitheliumof the uterus. Proc Natl Acad Sci USA. 1988; 85: 4350-1354. PubMed | Google Scholar

  3. Chambers TC. Phosphorylation of proteins involved in multidrug resisance, In: Gupta S, Tsuruo T, ed, Multidrug Resistance in Cancer Cells. Chichester, UK, John Wiley & Sons. 1996. Google Scholar

  4. Lankelma J, Spoelstra EC, Dekker H, Broxterman HJ. Evidence for daunomycin efflux from multidrug-resistant 2780AD human ovarian carcinoma cells against a concentration gradient. Biochim Biophys Acta. 1990;1055(3): 217-222. PubMed | Google Scholar

  5. Palmini A, Andermann F, Olivier A, Tampieri D, Robitaille Y, Andermann E et al. Focal neuronal migration disorders and intractable partial epilepsy: a study of 30 patients. Ann Neurol. 1991; 30(6): 741-749. PubMed | Google Scholar

  6. Lüders H, Acharya J, Baumgartner C, Benbadis S, Bleasel A, Burgess R et al. Semiological seizure classification. Epilepsia. 1998; 39(9): 1006-1013. PubMed | Google Scholar

  7. Hussein A, Abdulgalil A, Omer F, Eltoum H, Hamad A, El-Adil O, Mubarak B, Malkaldar M, Idris I, Alwidaa Y, Mahmoud E. Correlation between Serum Level of Antiepileptic Drugs and their Side Effects. Oman Medical Journal. 2010; 25 (1):17-21. PubMed | Google Scholar

  8. Osborn, H. Phenytoin and fosphenytoin toxicity: In: Tintinalli JE, Kelen GD, Stapczynski JS, eds, Emergency medicine: a compre-hensive study guide, 6th ed. New York, Mc-Graw Hill. 2004; p1117-1121. Google Scholar

  9. Sezak M. Prognostic Importance of P-glicoprotein Expression in Ewing Sarcoma. Ege Journal of Medicine. 2008;47(1):7-13. PubMed | Google Scholar

  10. Germann UA. P-Glycoprotein a madiator of multidrug resistance in tumour cells. European Journal of Cancer. 1996; 32(6): 927-944. PubMed | Google Scholar